Christer Ahlberg about the present and the future of Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma since June 2021, shares his thoughts about the company's current position and future vision.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Life Science Sweden interviews Kjell Andersson, CSO
During Life Science Sweden's conference "Pharma Outsourcing", Kjell Andersson, CSO at Cinclus Pharma, was interviewed about our drug candidate linaprazan glurate, which is an acid secretion inhibitor, a so-called P-CAB.
Read more
Improving the quality of life for people living with GERD
Millions of people around the world suffer from Gastroesophageal reflux disease, GERD. Most people can relate to discomfort caused by reflux and heartburn, two of the most common symptoms caused by light versions of GERD.
Read more